Singleron Biotechnologies
PrivateLast Round
Series B
Nov 8, 2021
Total Funding Raised
$170M
Company Overview
Singleron Biotechnologies is a biotechnology company that develops single-cell multi-omics analysis technologies, providing molecular diagnostic products and automated equipment for clinical diagnosis, health management, and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Singleron Biotechnologies Comparables
Compare Singleron Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mission Bio | 90% | |
| MobiDrop Biotech | 83% | |
| Beijing SeekGene BioSciences Co., Ltd. | 83% |
Singleron Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 8, 2021 | ||||
| Series A Extension | Dec 29, 2020 | ||||
| Series A Extension | Nov 9, 2020 | ||||
| Series A | Sep 6, 2020 | ||||
| VC Round | Jun 20, 2019 | ||||
Seed | May 1, 2018 |
Key People
Founding team and executive leadership
Singleron Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series A Extension, Series A, Series B |
| Lake Bleu Capital | Series B |
| Firstred Capital | Series B |
| MSA Capital | Series B |
| ARCH Venture Partners | Series A, Series B |
| Frees Fund | VC Round, Seed |
| ARCH Venture Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2025
Launched Tensor for single cell sequencing automation with Hamilton Bonaduz AG.
- Apr 9, 2025
Partnered with Hamilton Bonaduz AG to launch Tensor.
Singleron Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Singleron Biotechnologies's valuation, stock price, and market status.
Is Xingeyuan Biotechnology a public or private company?
Xingeyuan Biotechnology is a private company.
What is the current stock price of Xingeyuan Biotechnology?
Xingeyuan Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Xingeyuan Biotechnology worth (valuation)?
Valuation information for Xingeyuan Biotechnology is not publicly available.
Can I buy Xingeyuan Biotechnology stock?
Xingeyuan Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Xingeyuan Biotechnology's last funding round?
Xingeyuan Biotechnology's most recent funding round was Series B on November 8, 2021.
Who are the main investors in Xingeyuan Biotechnology?
Key investors in Xingeyuan Biotechnology include Lake Bleu Capital, Firstred Capital, Lilly Asia Ventures, Sherpa Healthcare Partners.
Will Xingeyuan Biotechnology IPO soon?
No public IPO plans have been announced for Xingeyuan Biotechnology.
How can I track Xingeyuan Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xingeyuan Biotechnology's secondary market activity and sign up for updates.